ACR staff can help members navigate questions on all areas of practice management.
Search results for: primary care providers
Summer 2024’s Awards, Appointments & Announcements in the World of Rheumatology
Dr. Megan Cooper Appointed Director of Pediatric Rheumatology & Immunology Division at WashU Megan A. Cooper, MD, PhD, a physician-scientist recognized internationally for her work in pediatric immunodeficiencies and immune dysregulation, took the reins of the Division of Pediatric Rheumatology and Immunology at Washington University School of Medicine, St. Louis, as director this past fall….
Make Way for the Interprofessional Rheumatology Team!
Editor’s note: Originally published on Oct. 12, 2023. Updated Feb. 28, 2024, to add fact sheets. According to the Agency for Healthcare Research and Quality (AHRQ), a leading cause of medical errors and poor care is a lack of communication between healthcare providers.1 As healthcare has evolved, the importance of holistic care has become more…
Noelle Rolle, MBBS, Begins New Term as Chair of Collaborative Initiatives Committee
Throughout her medical training, Noelle A. Rolle, MBBS, encountered many patients struggling with both rheumatic disease and issues of health equity and access to care. This drew her to rheumatology and, now, to lead the ACR’s Collaborative Initiatives Committee.
Polymyalgia Rheumatica: New Tricks for an Old Disease
Originally posted Feb. 13, 2023; reposted in conjunction with publication of the PMR supplement to the February 2024 issue of The Rheumatologist. PHILADELPHIA—Polymyalgia rheumatica (PMR) is a chronic inflammatory condition that almost exclusively affects individuals older than 50.1 First described in 1888, PMR has been a recognized rheumatic disease since at least 1957. Diagnosing the…
Study: Most Patients with PMR Aren’t Getting Steroid-Sparing Agents in First 2 Years
A minority of patients with polymyalgia rheumatica (PMR) who were new to rheumatology practice were prescribed steroid-sparing agents through two years of follow-up. This is according to a large, U.S.-based cohort study, published in Arthritis Care & Research, which also found that nearly two-thirds of the patients remained on glucocorticoids beyond one year.1 “Our study…
The Heterogeneity of Psoriatic Arthritis
SAN DIEGO—Differences between psoriatic arthritis and rheumatoid arthritis highlight the need for the development of imaging modalities, laboratory tests and other biomarkers that are explored and validated specifically for PsA to advance the goal of personalized or precision medicine. In this article, expert David S. Pisetsky, MD, PhD, explores the top research in psoriatic arthritis presented at ACR Convergence 2023.
Pakistani-Native Dr. Iman Qaiser Serves Choctaw Nation in Oklahoma
Some people may think Pakistan and Oklahoma share little in common, but one recent graduate of the rheumatology fellowship program at Louisiana State University, Shreveport (LSUS), School of Medicine disagrees. Iman Qaiser, MD, MBBS, a native of Pakistan who is starting a role as the only rheumatologist serving the Choctaw Nation of Oklahoma, sees natural…
Ethics Forum: Mitigation Tips for Health Disparities Among Rural & Indigenous Peoples
A common case scenario in our practice in North Dakota is a woman with rheumatoid arthritis on methotrexate monotherapy. She is a member of the Sisseton Wahpeton Oyate people and lives 90 miles from our rheumatology clinic. She currently has moderate disease activity, indicating the need for additional treatment. She does not have her own…
What’s Holding Back Biomarker Innovation, & How Can We Solve It?
Think about it. Most rheumatology labs are stuck in the 1960s. Translational biomarker research looks excellent on paper and in theory. However, many barriers exist from the bench to the bedside. This article highlights this problem for the rheumatology community and proposes practical solutions. Case in Point For an example, let’s examine systemic lupus erythematosus…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 45
- Next Page »